AT355282T
Biologically active methylene blue derivatives
Abstract
The invention deals with a-(I) phenothiazine imidazolium compounds, where a and b are independently (a) or (b), where z is the CH2,O,S,SO2,NH,NCH3,NC2H5,NCH2CH2OH, or NCOCH3,R1 and R2 independently is a straight-chain or branched-chain CnH2nY, where n is 1-6,Y H,F,Cl,Br,I,OH,OCH3,OC2H5,OC3H7,CN or OCOCH3, And is anti-XP-anion, p is 1, 2 or 3, but do not include both a and b-n (CH3) 2, or-n (CH2CH3) 2 compounds. Invention this invention also covers this compound as a PDT agents or applications of diagnostic reagents.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
46 members in 21 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 0113121 | United Kingdom | A | |
| 0123945 | United Kingdom | A |
Members46
| Document | Office | Kind | |
|---|---|---|---|
| GB0113121D0 | United Kingdom | D0 | |
| GB0123945D0 | United Kingdom | D0 | |
| CA2448303A1 | Canada | A1 | |
| WO02096896A1 | World Intellectual Property Organization (WIPO) | A1 | |
| NO20035327D0 | Norway | D0 | |
| KR20040015723A | Republic of Korea | A | |
| EP1392666A1 | European Patent Office (EPO) | A1 | |
| BR0209783A | Brazil | A | |
| US2004147508A1 | United States of America | A1 | |
| MXPA03010916A | Mexico | A | |
| CN1551872A | China | A | |
| JP2005500271A | Japan | A | |
| HK1063788A1 | Hong Kong, China | A1 | |
| ZA200309215B | South Africa | B | |
| AT355282TThis record | Austria | T | |
| ATE355282T1 | Austria | T1 | |
| NZ529682A | New Zealand | A | |
| EP1392666B1 | European Patent Office (EPO) | B1 | |
| DE60218454D1 | Germany | D1 | |
| PT1392666E | Portugal | E | |
| DK1392666T3 | Denmark | T3 | |
| EP1790642A1 | European Patent Office (EPO) | A1 | |
| AU2002256784B2 | Australia | B2 | |
| ES2280533T3 | Spain | T3 | |
| NO324321B1 | Norway | B1 | |
| DE60218454T2 | Germany | T2 | |
| US7371744B2 | United States of America | B2 | |
| US2008261960A1 | United States of America | A1 | |
| US2008268033A1 | United States of America | A1 | |
| US2008275033A1 | United States of America | A1 | |
| US2008312219A1 | United States of America | A1 | |
| KR20090010141A | Republic of Korea | A | |
| CN100491362C | China | C | |
| KR20090061684A | Republic of Korea | A | |
| JP2009280588A | Japan | A | |
| KR100957260B1 | Republic of Korea | B1 | |
| US7732439B2 | United States of America | B2 | |
| CA2448303C | Canada | C | |
| JP4554198B2 | Japan | B2 | |
| US7855197B2 | United States of America | B2 | |
| CN101928262A | China | A | |
| EP2275416A1 | European Patent Office (EPO) | A1 | |
| US7915254B2 | United States of America | B2 | |
| US8188074B2 | United States of America | B2 | |
| US2012302557A1 | United States of America | A1 | |
| CY1108091T1 | Cyprus | T1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 2726300
Titles2
- German
- BIOLOGISCH AKTIVE DERIVATE DES METHYLENBLAUS
- English
- BIOLOGICALLY ACTIVE DERIVATIVES OF METHYLENE BLAUS
Classification
- CPC, 27
- A61K49/003
- C07D279/18
- A61K8/4986
- A61K41/0057
- A61L2/0029
- A61L2/0082
- A61L2/08
- A61L2/232
- A61Q11/00
- A61P1/02
- A61P9/00
- A61P9/10
- A61P15/00
- A61P17/00
- A61P17/02
- A61P17/06
- A61P17/10
- A61P19/02
- A61P27/02
- A61P29/00
- A61P31/00
- A61P31/02
- A61P31/04
- A61P31/10
- A61P35/00
- A61P37/02
- A61P43/00
- IPC, 32
- A01N43 84
- A61F2 02
- A61F2 16
- A61F2 24
- A61F2 82
- A61J15 00
- A61K
- A61K8 49
- A61K31 5415
- A61K41 00
- A61K47 48
- A61K49 00
- A61M16 04
- A61M25 00
- A61M25 10
- A61P
- A61P9 00
- A61P9 10
- A61P15 00
- A61P17 00
- A61P17 02
- A61P17 06
- A61P17 10
- A61P19 02
- A61P27 02
- A61P29 00
- A61P31 04
- A61P35 00
- A61P43 00
- A61Q11 00
- C07D
- C07D279 18